(Q39667433)

13 September 2017

title

The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy (English)

1 reference

13 September 2017

1 reference

Xavier Durand

1

1 reference

13 September 2017

Evanguelos Xylinas

2

1 reference

13 September 2017

Camelia Radulescu

3

1 reference

13 September 2017

Rachel Haus-Cheymol

4

1 reference

13 September 2017

Stephane Moutereau

5

1 reference

13 September 2017

Gillaume Ploussard

6

1 reference

13 September 2017

Aurelien Forgues

7

1 reference

13 September 2017

Grégoire Robert

8

1 reference

13 September 2017

Francis Vacherot

9

1 reference

13 September 2017

Sylvain Loric

10

1 reference

13 September 2017

Yves Allory

11

1 reference

13 September 2017

Alain Ruffion

12

1 reference

13 September 2017

Alexandre de la Taille

13

1 reference

13 September 2017

publication date

5 January 2012

1 reference

13 September 2017

1 reference

13 September 2017

volume

110

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

43-49

1 reference

13 September 2017

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

Estimates of the cancer incidence and mortality in Europe in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

Pathological characteristics of prostate cancer detected through prostate specific antigen based screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

PCA3: a molecular urine assay for predicting prostate biopsy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

The Cautionary Tale of PSA Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10682.X

10.1111/J.1464-410X.2011.10682.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference